Business

Nature's Sunshine Reports Record Fourth Quarter and Full Year 2021 Financial Results

- Net Sales in the Fourth Quarter of 2021 Increased 15.9% to $117.9 Million, Marking the Sixth Consecutive Quarter of Record Net Sales - - Net Sales in 2021

articleNature's Sunshine Products, Inc.March 8, 20225/company/natures-sunshine-products-inc/news/natures-sunshine-reports-record-fourth-quarter-and-full-year-2021-financial-results
Nature's Sunshine Reports Record Fourth Quarter and Full Year 2021 Financial Results

About this update from Nature's Sunshine Products, Inc.

[{"type":"text","content":"- Net Sales in the Fourth Quarter of 2021 Increased 15.9% to $117.9 Million, Marking the Sixth Consecutive Quarter of Record Net Sales - - Net Sales in 2021 Increased 15.3% to a Company Record of $444.1 million - - Announces $30 Million Share Repurchase Program - LEHI, Utah, March 08, 2022 (GLOBE NEWSWIRE) -- Nature’s Sunshine Products, Inc. (Nasdaq: NATR) (“Nature’s Sunshine” and/or the “Company”), a leading natural health and wellness company of premium-quality herbal and nutritional products, reported financial results for the fourth quarter and full year ended December 31, 2021. Fourth Quarter 2021 Financial Highlights vs. Same Year-Ago Quarter Net sales increased 15.9% to a record $117.9 million compared to $101.7 million.GAAP net income increased 107.6% to $13.8 million, or $0.67 per diluted share, compared to $6.7 million, or $0.29 per diluted share.Adjusted net income per diluted share was $0.68, compared to an adjusted net income per diluted share of $0.32.Adjusted EBITDA increased 54.7% to $11.6 million compared to $7.5 million. Full Year 2021 Financial Highlights vs. 2020 Net sales increased 15.3% to a company record $444.1 million compared to $385.2 millionGAAP net income increased to $30.2 million, or $1.42 per diluted share, compared to $23.0 million, or $1.07 per diluted share.Adjusted net income per diluted share was $1.41, compared to an adjusted net income per diluted share of $1.07.Adjusted EBITDA increased 36.6% to $49.4 million compared to $36.2 million. Capital Allocation Nature’s Sunshine announced today that its board of directors authorized the repurchase of up to $30 million of the Company’s common shares. These authorized repurchases are in addition to the $15 million repurchase program that was announced in March 2021, which will be completed in the coming weeks. Repurchases may be made from time to time as market conditions warrant and are subject to regulatory considerations. Management Commentary “2021 was another record-breaking year for Nature’s Sunshine, as net sales and adjusted EBITDA reached historic highs,” said Terrence Moorehead, CEO of Nature’s Sunshine. “This was our sixth consecutive quarter of historic record-breaking growth, driven by effective implementation of our five global growth strategies. Importantly, 2021 was our first full-year implementing the new strategies, and while they...

More updates from Nature's Sunshine Products, Inc.